Evaluating Immune-Inflammatory Indices for Risk Stratification in Cardiovascular Disease: An Umbrella Review of Systematic Reviews and Meta-Analyses
Diagnostics · 12.11.2025 · 15 (22) · 2862
DOI: 10.3390/diagnostics15222862 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 12.11.2025. Verfasst von Hanxin Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Yong Loo Lin School of Medicine, National University of Singapore (NUS), NUHS Tower Block, 1E Kent Ridge Road Level 11, Singapore 119228, Singapore. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NUS-Agilent Hub for Translation and Capture [A*STAR, Industry Alignment Fund-Industry Collaboration Projects (IAF-ICP)], NMRC-Clinician Scientist Award (CSA) grant to Chester Drum, NUS-Agilent Hub for Translation and Capture [A*STAR, Industry Alignment Fund–Industry Collaboration Projects (IAF-ICP)].
Abstract (Originalsprache)
Background/Objectives: Although systematic reviews and meta-analyses have examined immune-inflammatory indices in cardiovascular disease (CVD), the evidence remains scattered and inconsistent. This umbrella review aims to synthesize findings and evaluate the overall predictive value of these indices for clinical outcomes.
Methods
We systematically searched PubMed, Cochrane Library, Web of Science, Embase, Scopus, and Medline for systematic reviews with meta-analyses assessing neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR), and systemic inflammation response index (SIRI) in patients with CVD. Study quality and certainty of evidence were appraised using AMSTAR-2 and GRADE, respectively.
Results
A total of 35 meta-analyses covering 106 unique outcomes were included, of which 87 showed significant associations. Elevated NLR and SII were consistently linked to higher risks of CVD mortality, major adverse cardiovascular events, myocardial infarction, heart failure, and stroke. PLR and SIRI were primarily associated with poor recovery from stroke and increased mortality in ST-elevation myocardial infarction. Specifically, the methodological quality of the included reviews was generally moderate to high according to AMSTAR-2, whereas none of the associations reached high certainty based on GRADE, with most rated as low or very low and about one-quarter as moderate certainty.
Conclusions
The overall certainty of evidence remains limited according to GRADE, alongside methodological heterogeneity, population variability, and inconsistent thresholds that further restrict the direct applicability of these findings in clinical practice. Nevertheless, available evidence indicates that elevated immune-inflammatory indices are likely associated with worse clinical outcomes in patients with CVD. Future research should prioritize establishing standardized cutoffs, improving methodological consistency, and validating these indices across diverse populations to support their integration into clinical risk-stratification frameworks.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Yong Loo Lin School of Medicine, National University of Singapore (NUS), NUHS Tower Block, 1E Kent Ridge Road Level 11, Singapore 119228, Singapore.
- Cardiovascular Research Institute (CVRI), National University Health System (NUHS), 14 Medical Drive, MD6 Level 8, Singapore 117599, Singapore.
- Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore 119228, Singapore.
- Xiangya School of Nursing, Central South University, 172 Tongzipo Road, Changsha 410013, China.
- College of Medicine and Health Science, Wuhan Polytechnic University, 68 Xuefu South Road, Changqing Garden, Wuhan 430023, China.
- Department of Operating Room, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
ORCID-Profile: Hanxin Liu, Pingwu Wang, Lik Hang Wu, Yuhan Li, Xinchen Ji, Ya-Ke Wu, Leroy Sivappiragasam Pakkiri, Chester Lee Drum
Förderung
- NUS-Agilent Hub for Translation and Capture [A*STAR, Industry Alignment Fund-Industry Collaboration Projects (IAF-ICP)]
- NMRC-Clinician Scientist Award (CSA) grant to Chester Drum
- NUS-Agilent Hub for Translation and Capture [A*STAR, Industry Alignment Fund–Industry Collaboration Projects (IAF-ICP)]
Zitieren
APA
Liu, H., Wang, P., Wu, L. H., Wu, F., Zhou, X., Li, Y., Su, H., Zang, J., Ji, X., Xiao, X., Wu, Y. K., Pakkiri, L. S., & Drum, C. L. (2025). Evaluating Immune-Inflammatory Indices for Risk Stratification in Cardiovascular Disease: An Umbrella Review of Systematic Reviews and Meta-Analyses. Diagnostics, 15(22), 2862. https://doi.org/10.3390/diagnostics15222862
Vancouver
Liu H, Wang P, Wu LH, Wu F, Zhou X, Li Y, et al. Evaluating Immune-Inflammatory Indices for Risk Stratification in Cardiovascular Disease: An Umbrella Review of Systematic Reviews and Meta-Analyses. Diagnostics. 2025;15(22):2862. doi:10.3390/diagnostics15222862
BibTeX
@article{Liu2025,
author = {Liu, Hanxin and Wang, Pingwu and Wu, Lik Hang and Wu, Fan and Zhou, Xinya and Li, Yuhan and Su, Hui and Zang, Jiayi and Ji, Xinchen and Xiao, Xueling and Wu, Ya-Ke and Pakkiri, Leroy Sivappiragasam and Drum, Chester Lee},
title = {Evaluating Immune-Inflammatory Indices for Risk Stratification in Cardiovascular Disease: An Umbrella Review of Systematic Reviews and Meta-Analyses},
journal = {Diagnostics},
year = {2025},
volume = {15},
number = {22},
pages = {2862},
doi = {10.3390/diagnostics15222862}
}
EUVIMED